Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 223153
Newswise: Use of venetoclax in reduced-intensity transplant conditioning regimen in patients with high-risk myeloid cancers shows promise in early trial
  • Embargo expired:
    7-Dec-2019 3:15 PM EST

Use of venetoclax in reduced-intensity transplant conditioning regimen in patients with high-risk myeloid cancers shows promise in early trial

Dana-Farber Cancer Institute

For patients with high-risk myeloid cancers undergoing a donor stem cell transplant, adding the targeted drug venetoclax to a reduced-intensity drug regimen prior to transplant is safe and does not impair the ability of the donor cells to take root in recipients’ bodies, a study led by Dana-Farber Cancer Institute researchers suggests.

Channels: All Journal News, Cancer, Pharmaceuticals, Stem Cells, Transplantation,

Released:
5-Dec-2019 12:05 PM EST
Open in New Tab
Comment
Newswise: Genomic features of AML in patients over age 60 can predict success of bone marrow stem cell transplant, research shows
  • Embargo expired:
    7-Dec-2019 8:45 AM EST

Genomic features of AML in patients over age 60 can predict success of bone marrow stem cell transplant, research shows

Dana-Farber Cancer Institute

For older patients with acute myeloid leukemia (AML), the prospects for success of a stem cell transplant can often be predicted based on the particular set of genetic mutations within the tumor cells, investigators at Dana-Farber Cancer Institute and other research centers will report today at the ASH Annual Meeting.

Channels: Blood, Cancer, Cell Biology, Medical Meetings,

Released:
6-Dec-2019 8:30 AM EST
Open in New Tab
Comment
Research Results
PennMed_logo.png
  • Embargo expired:
    7-Dec-2019 7:30 AM EST

Lymphoma Patients May Have New Path to Remission, Even When CAR T Therapy Fails

Perelman School of Medicine at the University of Pennsylvania

A new, experimental immunotherapy can put patients with B-cell non-Hodgkin lymphoma (NHL) that is resistant to or has come back after multiple other therapies, including CAR T therapy, into remission.

Channels: All Journal News, Cancer, Healthcare, Pharmaceuticals, Medical Meetings,

Released:
2-Dec-2019 12:00 PM EST
Open in New Tab
Comment
Research Results

Bing Crosby’s Legacy Alive and Well Here

Gonzaga University

Thousands of fans from 20 countries flock to Crosby House museum in busloads each year.

Channels: All Journal News, Arts and Entertainment,

Released:
6-Dec-2019 7:05 PM EST
Open in New Tab
Comment
Research Results

Arts and Humanities

Co-addiction of meth and opioids hinders treatment

University of Washington School of Medicine

A study published in the Journal of Substance Abuse Treatment of 799 patients in three locations found that methamphetamine use was associated with more than twice the risk for dropping out of treatment for opioid-use disorder.

Channels: Addiction, All Journal News, Drugs and Drug Abuse, Pharmaceuticals, Substance Abuse,

Released:
6-Dec-2019 7:00 PM EST
Open in New Tab
Comment
Feature
Research Results
Newswise: 'Cli-Fi' Literary Genre Puts a Human Face on Climate Change

'Cli-Fi' Literary Genre Puts a Human Face on Climate Change

California State University, Fullerton

Nicole Seymour, CSUF associate professor of English, comparative literature and linguistics, curates materials to teach courses focused on climate change and emotions, and climate fiction; helping students analyze benefits and drawbacks of the growing literature genre, "cli-fi."

Channels: All Journal News, Climate Science, Education, Environmental Science,

Released:
6-Dec-2019 6:00 PM EST
Open in New Tab
Comment
Feature Tip Sheet

Social and Behavioral Sciences

UM_School_Medicine.png

UM Medicine Launches Treatment Centers for Adult Neurodevelopmental Disabilities

University of Maryland School of Medicine

Launch of centers to treat adults with neurodevelopmental disorders, such as autism. These are the first in the state of Maryland and a pioneering approach for treatment across the United States.

Channels: Autism, Neuro,

Released:
6-Dec-2019 5:30 PM EST
Open in New Tab
Comment
Feature
Newswise: How to Build a 3D Map of the Universe – and Why

How to Build a 3D Map of the Universe – and Why

Department of Energy, Office of Science

In the 1980s, Saul Perlmutter at the Department of Energy’s (DOE) Lawrence Berkeley National Laboratory (LBNL) and his collaborators realized that they could use data about supernovae to research the history of the universe. They expected to see that very distant supernovae appear a bit brighter than they would in an expanding universe that wasn’t slowing in its growth. The data revealed something else entirely.

Channels: Physics, Space and Astronomy,

Released:
6-Dec-2019 5:05 PM EST
Open in New Tab
Comment
Announcement
Newswise: Networks in multiple sclerosis will be the focus at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2020 Forum

Networks in multiple sclerosis will be the focus at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2020 Forum

Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Approximately 1,200 researchers and clinicians are expected to attend the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) annual Forum Feb. 27-29, 2020, in West Palm Beach, Florida.

Channels: Neuro,

Released:
6-Dec-2019 4:50 PM EST
Open in New Tab
Comment
Feature

Showing results

110 of 223153

Chat now!
2.05168